Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Sirolimus 4Vincristine 1Prednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Kasabach-Merritt Syndrome × Clear all
NCT04448873 2023-09-26

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Children's Hospital of Fudan University

Phase 4 Completed
30 enrolled

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome

NCT02110069 2023-09-21

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Boston Children's Hospital

Phase 2 Terminated
4 enrolled 8 charts

Tufted angioma, Kaposiform Hemangioendothelioma, Hemangioendothelioma, Vascular Malformations, Kasabach-Merritt Syndrome

NCT04077515 2023-01-30

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Children's Hospital of Fudan University

Phase 4 Completed
92 enrolled

Kaposiform Hemangioendothelioma, Hemangioma, Kasabach-Merritt Syndrome

NCT03188068 2022-04-21

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

West China Hospital

Phase 2 Completed
30 enrolled

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡